Ian Simington, CEO Bimeda Europe said “we are looking forward to growing the Zootech business, which gives us a great direct platform in France, one of Europe’s largest veterinary markets. It enhances our range in the growing nutraceutical segment and we will be able to complement Zootech’s ruminant range with products from our own portfolio, particularly in the dairy sector, while enhancing the marketing commitment to the pet care range”.
Cargill said the sale of Zootech is consistent with the company's strategy of focusing on core animal nutrition solutions and premix activities. Zootech sells a broad range of ruminant and small animal products to vet customers throughout France. Terms of the agreement were not disclosed, but Cargill and Bimeda have agreed that Cargill's Provimi business will continue to manufacture ruminant bolus products for Bimeda.
“By exiting this non-core business we are able to better position our business in France to capitalize on growth opportunities in the animal nutrition industry,” said Mark Poeschl, vice president and group director for Cargill’s Provimi business. “In addition, Bimeda offers better opportunities for Zootech employees because it is better aligned with Bimeda’s core business activities.”